Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790222 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Despite a survival benefit, most patients with locally advanced PUC do not undergo definitive multimodal therapy. We advocate for a multidisciplinary-based treatment approach for these patients. Future prospective trials of multimodal therapy are crucial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David B. D.O., M.B.S., Elizabeth Ph.D., Benjamin T. M.D., MHA, Daniel M. M.D., Jay M.D., Alexander M.D., Richard E. M.D., Rosalia M.D., David Y.T. M.D., Robert G. M.D., Marc C. M.D., MSHP,